Subscribe to Newsletter

Content by Rob Coker:

Business & Regulation Standards & Regulation

Chemistry and Humility

| Rob Coker | 3 min read

Countries that struggled to acquire COVID-19 vaccines have not forgotten the inequity, and are reminding pharma giants that they shouldn’t either

Business & Regulation Standards & Regulation

Nowhere to Hide

| Rob Coker | 2 min read

Never underestimate the meticulousness with which authorities operate or the standards that businesses are expected to adhere to.

Discovery & Development Clinical Trials

Body Positive

| Rob Coker | 2 min read

Almirall’s humanized monoclonal antibody treatment for psoriasis brings positivity for patients

Manufacture Process Control

Advanced Manufacturing

| Rob Coker

Watch our roundtable discussion featuring experts from TrakCel, Ori Biotech, ScaleReady, and RoslinCT

Discovery & Development Drug Discovery

Science Fiction Comes to Life

| Rob Coker | 3 min read

Researchers are working on ways to introduce nanoscale artificial life-forms to viruses with the aim of mimicking the human immune system

Discovery & Development Drug Discovery

CRISPR With Caution

| Rob Coker | 3 min read

Deputy editor Rob Coker recalls his trip to the labs of Caszyme, Vilnius, where he spoke with CEO Monika Paule about the potential of genome editing

Business & Regulation Trends & Forecasts

The Battle Outside Raging

| Rob Coker | 2 min read

Climate change is real – it’s happening now – and it will take an awesome effort from the pharma industry to mitigate it

Discovery & Development Clinical Trials

Ignaz Semmelweis, We Salute You

| Rob Coker | 4 min read

In the second episode of the We Salute You series, we focus on much maligned Hungarian physician Ignaz Semmelweis

Discovery & Development Drug Discovery

Bringing Knowledge Back to Earth

| Rob Coker | 4 min read

The science behind space-based medicine is a bit of a slow-burner, but it’s on the launchpad

Manufacture Process Control

Redefining Manufacturing

| Rob Coker

Watch our roundtable discussion featuring experts from Terumo Blood and Cell Technologies, Orgenesis, ScaleReady, and BioBridge Global

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register